RS62492368 Unknown gene
Upload your DNA to see your genotype for this variant.
GWAS Studies (20)
| Trait | Risk Allele | OR / Beta | P-value | Study |
|---|---|---|---|---|
| Amiloride-sensitive amine oxidase [copper-containing] (analyte X15486.126) levels | A | OR: 1.12 | 2E-404 | PubMed |
| N-acetyl-isoputreanine levels | A | OR: 0.32 | 7E-90 | PubMed |
| Urine 1-methylhistamine levels in chronic kidney disease | A | OR: 0.29 | 2E-86 | PubMed |
| X-24020 levels | A | OR: 0.23 | 2E-72 | PubMed |
| (N(1) + N(8))-acetylspermidine levels | A | OR: 0.26 | 5E-60 | PubMed |
| X-23659 levels | A | OR: 0.23 | 4E-48 | PubMed |
| X-24020 levels | A | OR: 0.24 | 1E-47 | PubMed |
| High density lipoprotein cholesterol levels | — | — | 2E-27 | PubMed |
| Type 2 diabetes | A | — | 7E-24 | PubMed |
| Metabolite levels ((N(1) + N(8))-acetylspermidine) | A | OR: 0.27 | 1E-18 | PubMed |
| Carboxyethyl-gaba levels | A | OR: 0.15 | 3E-18 | PubMed |
| HDL cholesterol levels | G | β: 0.017 | 2E-16 | PubMed |
| Lymphocyte count (UKB data field 30120) | A | β: 0.016 | 8E-15 | PubMed |
| Type 2 diabetes | G | β: 0.031 | 2E-14 | PubMed |
| HDL cholesterol | A | β: 0.016 | 6E-13 | PubMed |
| Lymphocyte percentage (UKB data field 30180) | A | β: 0.015 | 3E-12 | PubMed |
| Type 2 diabetes | G | β: 0.034 | 6E-12 | PubMed |
| Lymphocyte count | A | β: 0.016 | 1E-11 | PubMed |
| Triglyceride levels (UKB data field 30870) | A | β: 0.014 | 1E-11 | PubMed |
| Triglyceride to HDL cholesterol ratio | A | β: 0.022 | 9E-11 | PubMed |